SmartTots
  • Home
  • About
    • Who We Are
    • FAQ
  • News
  • Resources
    • Healthcare Professionals Resources
    • Advice for Parents and Caregivers
    • Clinical Research Articles
    • Preclinical Research Articles
    • Live Stream
    • Newsletter Archive
    • Presentation Videos
    • Research and Grants
    • FDA Drug Safety Communication
  • Donor Recognition
  • Newsletter Signup
  • Contact
Select Page

Single, short duration exposure of general anesthesia appears to cause no cognitive harm in healthy, young children

by SmartTots | Jun 27, 2016 | Research Articles

A recent study concluded that very young, healthy children undergoing short surgical procedures requiring a single exposure to general anesthesia did not exhibit any effect on the cognitive outcomes tested, according to SmartTots, a public-private partnership of the International Anesthesia Research Society and the U.S. Food and Drug Administration (FDA). However, the group cautioned that more research is needed to identify problems that might exist under different circumstances.

The multi-center PANDA (Pediatric Anesthesia Neurodevelopment Assessment) study was led by researchers at Columbia University Medical Center and New-York-Presbyterian/Morgan Stanley Children’s Hospital. SmartTots was a partial funder of the study, which was published in the June 7, 2016 issue of the Journal of the American Medical Association.

The study, which compared 105 otherwise healthy children who were given general anesthesia for inguinal hernia surgery before the age of 3 with siblings who had not received anesthesia before age 3, showed no significant difference in IQ scores between the siblings when assessed between the ages of 8 and 15. The period of 0-3 years old is a critical time in the development of a child’s brain; animal studies and some previous epidemiological studies have shown general anesthesia to have a harmful effect when given during periods of rapid brain development. While this study included healthy children with a single exposure to general anesthesia, a different patient population, including children with a more complicated medical history and with multiple general anesthesia exposures, may show different results.

Read more at News Medical 

Categories

  • Clinical Articles
  • Events
  • News
  • Preclinical Articles
  • Research Articles

Recent Posts

  • Update on SmartTots Initiative and Research Funding on April 16, 2023
  • Comparer Pommes et Oranges: Perils of Translating Rodent Studies to Human Outcomes
  • Repeated sevoflurane exposures inhibit neurogenesis by inducing the upregulation of glutamate transporter 1 in astrocytes.
  • The propofol-induced mitochondrial damage in fetal rat hippocampal neurons via the AMPK/P53 signaling pathway.
  • Ketamine modulates neural stem cell differentiation by regulating TRPC3 expression through the GSK3β/β-catenin pathway.

About SmartTots

The SmartTots program is a multi-year collaborative effort designed to increase the safety of anesthetic and sedative drugs for the millions of children who undergo anesthesia and sedation each year.

Contact SmartTots

90 New Montgomery Street
Suite 412
San Francisco, CA 94105
Phone: 415-296-6905
Fax: 415-296-6901

E-mail: [email protected]

Tax Information

SmartTots is a research initiative of the IARS, a 501 c (3) non-profit organization.

Federal Tax ID 34-0750348

GuideStar/Candid

Guidestar

View our Summary

  • Privacy Policy
  • Terms of Use
  • International Anesthesia Research Society
  • Newsletter Signup
  • Twitter

Designed by Elegant Themes | Powered by WordPress